# FDA recall Z-2192-2017

> **GE Healthcare, LLC** · Class II · device recall initiated 2017-05-19.

## Product

GE Healthcare Discovery IQ   X-ray system

## Reason for recall

It was discovered that an issue has been identified that can result in a scan starting before the prescribed delay has completed.

## Distribution

Worldwide Distribution - USA (nationwide) including Puerto Rico and to the countries of :  Japan, Jordan, Kazakhstan, Korea ( Republic of) Kuwait, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malaysia, Malta, Martinique, Mauritania, Mexico, Moldova, Morocco, Nambia, Netherlands, New Caledonia, New Zealand, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Serbia, Reunion, Romania, Russia, Rwanda, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain Sweden, Switzerland, Syria, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Vietam and Yemen.

## Key facts

- **Recall number:** Z-2192-2017
- **Recalling firm:** GE Healthcare, LLC
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2017-05-19
- **Report date:** 2017-06-21
- **Termination date:** 2018-07-29

- **Voluntary/Mandated:** FDA Mandated
- **Location:** Waukesha, WI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2192-2017

## Citation

> AI Analytics. FDA recall Z-2192-2017. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/Z-2192-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*